Disc Medicine stock soars: take profit or buy into strength?

Disc Medicine (IRON) shares ripped higher on Monday morning after the company's experimental blood-disorder treatment, bitopertin, delivered positive Phase 3 results. In its press release, management ...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。